SELLAS Life Sciences announces pricing of upsized $24.2 million public offering
SELLAS Life Sciences announced pricing of an underwritten public offering of 11,520,000 shares of common stock or, in lieu of shares of common stock, pre-funded warrants exercisable for common stock, and accompanying common stock warrants to purchase an aggregate of 11,520,000 shares of stock. July 12, 2018